227Th-EDTMP: a potential therapeutic agent for bone metastasis.

Nucl Med Biol

School of Health Sciences, Faculty of Medicine, Kanazawa University, 5-11-80 Kodatsuno, Kanazawa, Ishikawa 920-0942, Japan.

Published: October 2004

The biodistribution of 227Th-EDTMP and retention of its daughter nuclide 223Ra were examined. 227Th-EDTMP was found to show high uptake and long-term retention in bone. The clearance of 227Th-EDTMP from blood and soft tissues was rapid and the femur-to-tissue uptake ratios reached more than 100 within 30 min for all tissues except the kidney. Seven and 14 days after injection of 227Th-EDTMP, the retention index of 223Ra in bone showed high values, and the differences between these time points were not significant. Therefore, 227Th-EDTMP is a potential radiotherapeutic agent for bone metastasis.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.nucmedbio.2004.05.001DOI Listing

Publication Analysis

Top Keywords

227th-edtmp potential
8
agent bone
8
bone metastasis
8
227th-edtmp retention
8
227th-edtmp
6
potential therapeutic
4
therapeutic agent
4
bone
4
metastasis biodistribution
4
biodistribution 227th-edtmp
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!